COVID-19 is an acute respiratory distress syndrome and is often accompanied by gastrointestinal symptoms The SARS-CoV-2 has been traced not only in nasopharyngeal and mid-nasal swabs but also in stool and rectal swabs of COVID-19 patients The gut microbiota is important for an effective immune response as it ensures that unfavorable immune reactions in lungs and other vital organs are regulated The human gut-lung microbiota interplay provides a framework for therapies in the treatment and management of several pulmonary diseases and infections Here, we have collated data from COVID-19 studies, which suggest that bacterial co-infections as well as the gut-lung cross talk may be important players in COVID-19 disease prognosis Our analyses suggests a role of gut microbiome in pathogen infections as well as in an array of excessive immune reactions during and post COVID-19 infection recovery period
Interplay between severities of COVID-19 and the gut microbiome: implications of bacterial co-infections?